Unknown

Dataset Information

Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids.


ABSTRACT: Cannabinoids and related drugs generate profound behavioral effects (such as analgesic effects) through activating CNR1 (cannabinoid receptor 1 [brain]). However, repeated cannabinoid administration triggers lysosomal degradation of the receptor and rapid development of drug tolerance, limiting the medical use of marijuana in chronic diseases. The pathogenic mechanisms of cannabinoid tolerance are not fully understood, and little is known about its prevention. Here we show that a protein involved in macroautophagy/autophagy (a conserved lysosomal degradation pathway), BECN2 (beclin 2), mediates cannabinoid tolerance by preventing CNR1 recycling and resensitization after prolonged agonist exposure, and deletion of Becn2 rescues CNR1 activity in mouse brain and conveys resistance to analgesi

SUBMITTER: Kuramoto K 

PROVIDER: S-EPMC5082783 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature